Prochlorperazine

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved January 1998

Specific Treatments:

Severe nausea and vomiting, and management of psychotic disorders

Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

Prochlorperazine maleate has been approved in 5 mg and 10 mg tablets for the control of severe nausea and vomiting, and for management of the manifestations of psychotic disorders. It is the generic equivalent of SmithKline Beecham's Compazine.